ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

37,016Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 2604

$2.82M Total Retail Price of All Prescriptions

Rank: 2 out of 2604

648 Patients Receiving at Least One Drug in Part D
19%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 648 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

77% of this provider’s 648 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

5% of this provider’s 4,762 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$76 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

57 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
HYDROCODONE-ACETAMINOPHEN 3,745 395 S3 1 1
AZITHROMYCIN 1,604 150 10 2 33
CARISOPRODOL 1,494 101 R 3 54
PROAIR HFA 1,276 163 10 4 27
FUROSEMIDE 947 106 5 8
POTASSIUM CHLORIDE 902 130 6 16
SYMBICORT 858 93 10 7 105
GABAPENTIN 807 58 8 12
FLUTICASONE PROPIONATE 797 54 9 31
CIPROFLOXACIN HCL 797 87 9 59
SAPHRIS 707 28 10 11 211
ZOLPIDEM TARTRATE 666 102 12 21
TRAMADOL HCL 627 33 13 15
LISINOPRIL 582 149 14 3
PREDNISONE 556 28 15 34
AMLODIPINE BESYLATE 538 124 16 6
VIIBRYD 507 18 10 17 250
METFORMIN HCL 481 101 18 7
OMEPRAZOLE 467 82 19 5
CYMBALTA 458 35 20 44
SPIRIVA 409 20 21 45
ORPHENADRINE CITRATE 379 41 R 10 22 207
FLUCONAZOLE 378 24 10 23 160
SIMVASTATIN 361 99 24 2
CYCLOBENZAPRINE HCL 351 14 R 25 43
IBUPROFEN 345 36 26 32
CEFDINIR 337 11 10 27 234
VENTOLIN HFA 326 47 28 63
PROMETHAZINE HCL 314 34 R 29 88
COLCRYS 308 40 10 30 232
NASONEX 300 28 31 223
METOPROLOL TARTRATE 296 67 32 9
RANITIDINE HCL 293 41 33 25
TRIAMTERENE-HCTZ 290 37 34 55
NAPROXEN SODIUM 289 0 10 35 216
SINGULAIR 278 44 36 120
PANTOPRAZOLE SODIUM 265 37 37 64
DULERA 262 35 10 38 304
NEXIUM 251 15 39 53
TRIAMCINOLONE ACETONIDE 247 40 40 125
SOLARAZE 242 24 41 275
CYPROHEPTADINE HCL 237 15 R 10 42 278
LYRICA 228 15 43 79
VOLTAREN 218 44 44 148
BYSTOLIC 198 27 45 165
SULFAMETHOXAZOLE-TRIMETHOPRIM 196 19 46 91
NYSTATIN 194 19 47 100
METHOCARBAMOL 184 12 R 48 153
AMITIZA 174 44 49 345
PROMETHAZINE VC 171 0 R 10 50 268
POLYETHYLENE GLYCOL 3350 168 28 51 42
FENTANYL 167 39 S2 52 48
NIFEDIPINE ER 167 30 52 121
KETOCONAZOLE 151 17 54 197
CRESTOR 149 18 55 47
NAMENDA 145 61 56 37
LEVOTHYROXINE SODIUM 138 24 57 4
ACTOS 127 19 58 116
ESCITALOPRAM OXALATE 127 0 58 73
TIZANIDINE HCL 123 16 60 161
LANTUS 122 25 61 40
VIMOVO 121 13 10 62 378
DONEPEZIL HCL 112 42 63 28
ESTRADIOL 107 0 R 64 196
AMPHETAMINE SALT COMBO 106 0 S2 65 235
MONTELUKAST SODIUM 106 16 65 213
QVAR 106 26 65 151
METRONIDAZOLE 104 0 68 243
BUMETANIDE 102 37 69 70
ADVAIR DISKUS 102 0 69 41
FEXOFENADINE HCL 99 0 71 402
WARFARIN SODIUM 97 33 72 13
OLANZAPINE 95 0 73 115
QUETIAPINE FUMARATE 95 0 73 66
SUMATRIPTAN SUCCINATE 94 0 75 245
CEPHALEXIN 92 0 76 74
LEVETIRACETAM 91 0 77 96
SAVELLA 91 0 77 408
MOMETASONE FUROATE 90 16 79 358
SERTRALINE HCL 84 0 80 23
DICYCLOMINE HCL 83 21 81 201
ISOSORBIDE MONONITRATE ER 83 47 81 38
TAMSULOSIN HCL 82 36 83 30
PLAVIX 78 34 84 75
AMOXICILLIN 78 0 84 99
DOXYCYCLINE HYCLATE 77 0 86 122
CIPRODEX 77 0 86 425
MIRTAZAPINE 77 0 86 52
SEROQUEL 76 0 89 149
ABILIFY 76 16 89 130
CARVEDILOL 74 23 91 26
NITROSTAT 74 12 91 241
ALAVERT 73 0 10 93 430
TOBRAMYCIN-DEXAMETHASONE 73 12 93 430
ATORVASTATIN CALCIUM 72 23 95 19
TERCONAZOLE 72 0 95 432
SURE COMFORT 71 0 97 238
CLOPIDOGREL 71 30 97 39
GLIPIZIDE 71 34 97 51
CITALOPRAM HBR 70 0 100 18
ADVAIR HFA 69 0 101 436
METHADONE HCL 69 0 S2 101 67
HYDROCHLOROTHIAZIDE 69 13 101 10
LIDODERM 68 25 104 80
TRAZODONE HCL 66 24 105 46
CLINDAMYCIN PHOSPHATE 65 0 106 353
TAMIFLU 64 0 107 376
CLONIDINE HCL 64 0 107 56
ATENOLOL 62 21 109 11
NALBUPHINE HCL 61 16 110 453
FLUOXETINE HCL 61 0 110 49
NOVOLOG 60 24 112 89
FAMOTIDINE 59 15 113 68
OXYBUTYNIN CHLORIDE 59 11 113 92
PRENATAL PLUS 59 0 113 461
DIPHENOXYLATE-ATROPINE 58 0 116 387
ACETAMINOPHEN-CODEINE 57 25 S3 117 60
HYDROXYZINE PAMOATE 57 0 R 117 293
BUPROPION XL 57 0 117 264
EXFORGE HCT 56 15 120 471
PRAMIPEXOLE DIHYDROCHLORIDE 56 16 120 266
GEMFIBROZIL 55 0 122 87
PHENYTOIN SODIUM EXTENDED 55 0 122 135
MEDROXYPROGESTERONE ACETATE 54 0 124 481
ALVESCO 53 0 125 483
SINGLE USE SWAB 52 0 126 221
ALLOPURINOL 52 17 126 35
AMITRIPTYLINE HCL 51 0 R 128 82
LORATADINE 51 0 128 276
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 3, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.